$ASND

3 theses
bullish 33%neutral 0%bearish 67%
Avg return (3m)
+9.2%
Win rate (3m)
100% (1 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 19, 4:55 PM ET
$ASNDSEC Form 4bearish
Sold 20,000 @ $263.89 avg · $5,277,720 · 2026-11-17

Form 4: PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG sold ASND

PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (EVP & Chief Admin Officer at Ascendis Pharma A/S) reported an open-market sale of 20,000 shares of ASND at an average $263.89, roughly $5,277,720, in a Form 4 filed 2026-11-18.

At post $270.33Now $255.96-5.3% since postedas of Nov 19, 4:55 PM ET
1d-5.3%
3d—
1w—
1m—
3m—
6m—
1y—
ASND $260.00 P · Dec 18
Finishes below $260.00 in 29 days
51%
View filing on SEC.gov →
$ASNDSEC Form 4bearish
Sold 3,000 @ $270.19 avg · $810,570 · 2026-09-08

Form 4: Bodenhoff Mads sold ASND

Bodenhoff Mads (SVP & PAO at Ascendis Pharma A/S) reported an open-market sale of 3,000 shares of ASND at an average $270.19, roughly $810,570, in a Form 4 filed 2026-09-09.

At post $260.81Now $255.96-1.9% since postedas of Nov 19, 4:55 PM ET
1d+0.2%
3d+1.0%
1w-5.0%
1m-12.1%
3m—
6m—
1y—
View filing on SEC.gov →
$ASNDSEC Form 4bullish
BIENAIME JEAN JACQUES · Ascendis Pharma A/S · 93d agono track record yet
Long 2,000 shares of ASND
Bought 2,000 @ $246.33 avg · $492,654 · 2026-08-14

Form 4: BIENAIME JEAN JACQUES bought ASND

BIENAIME JEAN JACQUES (Director at Ascendis Pharma A/S) reported an open-market purchase of 2,000 shares of ASND at an average $246.33, roughly $492,654, in a Form 4 filed 2026-08-18.

At post $248.85Now $255.96+2.9% since postedas of Nov 19, 4:55 PM ET
1d+4.3%
3d+1.8%
1w+1.7%
1m-3.9%
3m+9.2%
6m—
1y—
View filing on SEC.gov →

End of results.